Northwest Biotherapeutics reported -12286000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -35997000 20.08M
Applied Genetic Technologies AGTC:US $ -13481000 4.8M
AstraZeneca AZN:LN 2.2B 673M
Bristol Myers Squibb BMY:US $ 3197M 9M
Celldex Therapeutics CLDX:US $ -23257000 2.92M
Cti Biopharma CTIC:US $ -35100000 275K
Cytori Therapeutics CYTX:US $ -5120000 1.19M
Cytrx CYTR:US -1294610 692.11K
Eisai 4523:JP 7.43B 28.23B
Genocea Biosciences GNCA:US $ -15773000 2.36M
Infinity Pharmaceuticals INFI:US -12407000 907K
Merk MRK:US $ 5711M 652M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Northwest Biotherapeutics NWBO:US -12286000 1.61M
Pfizer PFE:US $ 12099M 2104M